Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease

Published:2015-02 Issue: Volume:30 Page:32-43
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Del Vecchio Alfred M.,Branigan Patrick J.^ORCID,Barnathan Elliot S.,Flavin Susan K.,Silkoff Philip E.,Turner Ronald B.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference243 articles.

1. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach;W.H.O., World Health Organization,2007

2. Chronic obstructive pulmonary disease (COPD);W.H.O., World Health Organization,2011

3. Deaths: final data for 2010;Murphy;Natl Vital Stat Rep,2013

4. Asthma prevalence, health care use, and mortality: United States, 2005–2009;Akinbami;Natl Health Stat Rep,2011

5. Global initiative for asthma;NHLBI,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on virus-induced asthma exacerbations;Expert Review of Clinical Immunology;2023-07-24

2. In Vitro, In Vivo, and Ex Vivo Models to Study Mixed Bacterial and Fungal Biofilms;Springer Series on Biofilms;2022-12-19

3. Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial;Thorax;2021-10-29

4. Are placebo controls necessary in controlled human infection trials for vaccines?;The Lancet Infectious Diseases;2020-04

5. Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease;Respiratory Research;2019-09-13